NZ251131A - 2-carboxy-(or 2-carboxymethyl)-3,4-dihydroxybenzo[b]pyran derivatives; gamma- and delta-lactones thereof; pharmaceutical compositions and preparatory methods - Google Patents

2-carboxy-(or 2-carboxymethyl)-3,4-dihydroxybenzo[b]pyran derivatives; gamma- and delta-lactones thereof; pharmaceutical compositions and preparatory methods

Info

Publication number
NZ251131A
NZ251131A NZ251131A NZ25113193A NZ251131A NZ 251131 A NZ251131 A NZ 251131A NZ 251131 A NZ251131 A NZ 251131A NZ 25113193 A NZ25113193 A NZ 25113193A NZ 251131 A NZ251131 A NZ 251131A
Authority
NZ
New Zealand
Prior art keywords
compound
dihydro
tetramethyl
methyl
methano
Prior art date
Application number
NZ251131A
Other languages
English (en)
Inventor
Johann Martin Grisar
Margaret Anne Petty
Frank Norbert Bolkenius
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NZ251131A publication Critical patent/NZ251131A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Paints Or Removers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ251131A 1992-04-06 1993-03-08 2-carboxy-(or 2-carboxymethyl)-3,4-dihydroxybenzo[b]pyran derivatives; gamma- and delta-lactones thereof; pharmaceutical compositions and preparatory methods NZ251131A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400957 1992-04-06

Publications (1)

Publication Number Publication Date
NZ251131A true NZ251131A (en) 1996-01-26

Family

ID=8211647

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ251131A NZ251131A (en) 1992-04-06 1993-03-08 2-carboxy-(or 2-carboxymethyl)-3,4-dihydroxybenzo[b]pyran derivatives; gamma- and delta-lactones thereof; pharmaceutical compositions and preparatory methods

Country Status (18)

Country Link
EP (1) EP0635010B1 (da)
JP (1) JP3248183B2 (da)
KR (1) KR100243820B1 (da)
AT (1) ATE146175T1 (da)
AU (1) AU667889B2 (da)
CA (1) CA2132745C (da)
DE (1) DE69306559T2 (da)
DK (1) DK0635010T3 (da)
ES (1) ES2098030T3 (da)
FI (1) FI112658B (da)
GR (1) GR3022471T3 (da)
HU (1) HU217426B (da)
IL (1) IL105320A (da)
NO (1) NO307088B1 (da)
NZ (1) NZ251131A (da)
TW (1) TW232014B (da)
WO (1) WO1993020058A1 (da)
ZA (1) ZA932326B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
CN115073413B (zh) * 2022-05-17 2023-06-02 中山大学 一种苯并环醚类倍半萜类化合物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
FI944656A (fi) 1994-10-05
FI944656A0 (fi) 1994-10-05
ATE146175T1 (de) 1996-12-15
ES2098030T3 (es) 1997-04-16
DE69306559D1 (de) 1997-01-23
NO943727D0 (no) 1994-10-05
JPH07505392A (ja) 1995-06-15
FI112658B (fi) 2003-12-31
NO307088B1 (no) 2000-02-07
CA2132745C (en) 2000-03-21
AU667889B2 (en) 1996-04-18
KR950700896A (ko) 1995-02-20
IL105320A0 (en) 1993-08-18
CA2132745A1 (en) 1993-10-14
KR100243820B1 (ko) 2000-03-02
GR3022471T3 (en) 1997-05-31
ZA932326B (en) 1993-10-18
IL105320A (en) 1998-02-08
TW232014B (da) 1994-10-11
EP0635010B1 (en) 1996-12-11
DE69306559T2 (de) 1997-04-10
HUT68982A (en) 1995-08-28
DK0635010T3 (da) 1996-12-30
EP0635010A1 (en) 1995-01-25
NO943727L (no) 1994-12-05
HU9402863D0 (en) 1995-01-30
HU217426B (hu) 2000-01-28
JP3248183B2 (ja) 2002-01-21
WO1993020058A1 (en) 1993-10-14
AU3797293A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
US5484810A (en) Tissue protective tocopherol analogs
EP0635010B1 (en) Novel cardioprotective agents
US5698696A (en) Process for preparing 2,3-dihydro-benzofuranol derivatives
EP0635009B1 (en) Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols
US5545660A (en) Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5510373A (en) Cardioprotective agents
EP0635011B1 (en) Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
EP0337885B1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
US5500444A (en) Cardioprotective tocopherol analogs
AU705004B2 (en) 2,3-dihydro-benzofuranol derivatives and process for resolving the same
US5721233A (en) Derivatives of 2,3-dihydro benzofuranols
EP4441024A1 (en) Process for the synthesis and purification of cannabinoic acids and acylated derivatives thereof